Skinny-Labeled Generics Saved Medicare Billions Over Six Years

“Skinny labeling” on 15 generic drugs saved Medicare an estimated $14.6 billion from 2015-2021, but patent lawsuits may threaten the practice, according to an analysis published in the Annals of Internal Medicine.
Source: Drug Industry Daily